Greenspring Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Greenspring Advisors's LLY Position: Q3 2026 in Review
Greenspring Advisors increased its Eli Lilly (LLY) stake by 105% in Q3 2026, buying an estimated $3.94M and bringing the position to 6,512 shares worth $7.53M. The position accounts for 0.34% of the portfolio, ranked #39.
Greenspring Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 2,991 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Greenspring Advisors held 6,512 shares of Eli Lilly worth $7.53M as of Q3 2026.
- Greenspring Advisors bought 3,341 Eli Lilly shares in Q3 2026, an estimated $3.94M.
- Eli Lilly made up 0.34% of Greenspring Advisors's portfolio in Q3 2026, its #39 holding.
- Greenspring Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 2,991 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Greenspring Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.